ANTX · AN2 Therapeutics, Inc.

$5.79 -0.17 (-2.85%) At close · Aug 20

Market Cap

$218.49M

37.74M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Easom	President, Chief Executive Officer and Board Chair	$603,750	—	$164,133	$275,539	$332,063	$7,500	$1,382,985
Josh Eizen	Chief Legal Officer and Chief Operating Officer	$450,000	—	$66,105	$110,975	$180,000	—	$807,080
Lucy Day	Chief Financial Officer	$447,200	—	$52,545	$88,211	$178,880	$7,500	$774,336

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Easom	President, Chief Executive Officer and Board Chair	$603,750	—	$297,000	$508,820	$249,047	$7,500	$1,666,117
Josh Eizen	Chief Legal Officer and Chief Operating Officer	$435,375	—	$280,020	$211,342	$130,613	—	$1,057,350
Paul Eckburg	Former Chief Medical Officer	$325,500	—	$90,000	$154,188	—	$376,813	$946,501
Lucy Day	Chief Financial Officer	$447,200	—	$82,500	$141,339	$134,160	$7,500	$812,699

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Easom	President, Chief Executive Officer and Board Chair	$575,000	—	—	$2,422,848	$345,000	—	$3,342,848
Lucy Day	Chief Financial Officer	$430,000	—	—	$888,058	$206,400	—	$1,524,458
Paul Eckburg	Former Chief Medical Officer	$465,000	—	—	$765,586	$223,200	—	$1,453,786
Josh Eizen	Chief Legal Officer and Chief Operating Officer	$410,000	—	—	$541,144	$196,800	—	$1,147,944

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Easom	President and Chief Executive Officer	$481,185	—	—	$2,767,815	$216,533	—	$3,465,533
Paul Eckburg	Chief Medical Officer	$427,399	—	—	$811,893	$153,864	—	$1,393,156
Joshua Eizen	Chief Legal Officer	$101,742	—	—	$1,216,194	$36,627	—	$1,354,563
Lucy Day	Chief Financial Officer	$379,934	—	—	$811,893	$136,776	—	$1,328,603

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Easom	President, Chief Executive Officer and Director	$377,300	—	—	$1,190,689	$151,000	—	$1,718,989
Paul Eckburg	Chief Medical Officer	$258,125	—	—	$567,928	$77,000	—	$903,053

Executive changes

Person	Role	Change	Effective	Filed
Sarah Williams	Vice President, Controller and Principal Accounting Officer	Appointed	2026-02-01	2026-01-29
Joshua Eizen	Chief Legal Officer	Appointed	2024-11-04	2024-11-05
Joshua Eizen	Chief Operating Officer	Appointed	2024-11-04	2024-11-05
Paul Eckburg, M.D.	Chief Medical Officer	Terminated	2024-08-30	2024-08-08
Lucy Day	Principal Accounting Officer	Appointed	2023-09-01	2023-09-08
Margaret (Maggie) M. FitzPatrick	Class II Director	Appointed	2022-05-05	2022-05-09

Key facts CIK 1880438 CUSIP 037326105 13F (30d) 66 filings 66 filers Visit website Investor relations